BROOKE PATE: Open Payments
NPI 1821531583 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,140 in 110 payments from 17 companies in 2025. Trend: 2023 $2,102 · 2024 $2,443 · 2025 $2,140
Food & beverage: $2,140
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $446 |
| ABBVIE INC. | 17 | $340 |
| PFIZER INC. | 19 | $310 |
| Novo Nordisk Inc | 19 | $292 |
| Dexcom, Inc. | 5 | $117 |
| Phathom Pharmaceuticals, Inc. | 6 | $109 |
| Lilly USA, LLC | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Amgen Inc. | 3 | $58 |
Products named: AIRSUPRA, NURTEC ODT, QULIPTA, Wegovy, VRAYLAR, Dexcom G6 Transmitter, VOQUEZNA, JARDIANCE.
Industry payments across FL — which companies pay providers there.
